WallStSmart

Photronics Inc (PLAB)vsSynopsys Inc (SNPS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Synopsys Inc generates 829% more annual revenue ($8.01B vs $862.22M). PLAB leads profitability with a 15.8% profit margin vs 13.8%. PLAB appears more attractively valued with a PEG of 2.64. PLAB earns a higher WallStSmart Score of 61/100 (C+).

PLAB

Buy

61

out of 100

Grade: C+

Growth: 5.3Profit: 7.0Value: 3.3Quality: 8.5
Piotroski: 3/9Altman Z: 6.58

SNPS

Hold

47

out of 100

Grade: D+

Growth: 6.7Profit: 5.0Value: 3.0Quality: 4.5
Piotroski: 1/9Altman Z: 1.48
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

PLABSignificantly Overvalued (-47.4%)

Margin of Safety

-47.4%

Fair Value

$25.85

Current Price

$49.48

$23.63 premium

UndervaluedFair: $25.85Overvalued

Intrinsic value data unavailable for SNPS.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

PLAB4 strengths · Avg: 9.0/10
Debt/EquityHealth
0.0010/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
6.5810/10

Safe zone — low bankruptcy risk

Price/BookValuation
2.4x8/10

Reasonable price relative to book value

Operating MarginProfitability
24.4%8/10

Strong operational efficiency at 24.4%

SNPS2 strengths · Avg: 9.5/10
Revenue GrowthGrowth
65.5%10/10

Revenue surging 65.5% year-over-year

Market CapQuality
$92.45B9/10

Large-cap with strong market position

Areas to Watch

PLAB2 concerns · Avg: 2.5/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
2.642/10

Expensive relative to growth rate

SNPS4 concerns · Avg: 2.5/10
Return on EquityProfitability
5.5%3/10

ROE of 5.5% — below average capital efficiency

Piotroski F-ScoreQuality
1/93/10

Weak financial health signals

PEG RatioValuation
3.172/10

Expensive relative to growth rate

P/E RatioValuation
74.3x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : PLAB

The strongest argument for PLAB centers on Debt/Equity, Altman Z-Score, Price/Book. Profitability is solid with margins at 15.8% and operating margin at 24.4%.

Bull Case : SNPS

The strongest argument for SNPS centers on Revenue Growth, Market Cap. Revenue growth of 65.5% demonstrates continued momentum.

Bear Case : PLAB

The primary concerns for PLAB are Piotroski F-Score, PEG Ratio.

Bear Case : SNPS

The primary concerns for SNPS are Return on Equity, Piotroski F-Score, PEG Ratio. A P/E of 74.3x leaves little room for execution misses.

Key Dynamics to Monitor

PLAB profiles as a mature stock while SNPS is a growth play — different risk/reward profiles.

PLAB carries more volatility with a beta of 1.43 — expect wider price swings.

SNPS is growing revenue faster at 65.5% — sustainability is the question.

SNPS generates stronger free cash flow (822M), providing more financial flexibility.

Bottom Line

PLAB scores higher overall (61/100 vs 47/100), backed by strong 15.8% margins. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Photronics Inc

TECHNOLOGY · SEMICONDUCTOR EQUIPMENT & MATERIALS · USA

Photronics, Inc. manufactures and sells photomask products and services in the United States, Taiwan, Korea, Europe, China, and internationally. The company is headquartered in Brookfield, Connecticut.

Visit Website →

Synopsys Inc

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

Synopsys is an American electronic design automation company that focuses on silicon design and verification, silicon intellectual property and software security and quality. Products include logic synthesis, behavioral synthesis, place and route, static timing analysis, formal verification, hardware description language (SystemC, SystemVerilog/Verilog, VHDL) simulators, and transistor-level circuit simulation.

Visit Website →

Want to dig deeper into these stocks?